Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

NCT07187947 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Gender Incongruence
Cardiovascular (CV) Risk
Cardiovascular Disease Risk Factor
Cardiovascular Disease Acute
Cardiovascular Health Status
Cardiovascular Disease (CVD)
Cardiovascular Disease Prevention

Interventions

DRUG: Feminizing GAHT
DRUG: Masculinizing GAHT

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna